Biogen Inc (BIIB)
168.00
+2.21
(+1.33%)
USD |
NASDAQ |
Nov 14, 11:26
Biogen Total Return Level: 165.79 for Nov. 13, 2024
Total Return Level Chart
Historical Total Return Level Data
Date | Value |
---|---|
November 13, 2024 | 165.79 |
November 12, 2024 | 168.28 |
November 11, 2024 | 172.03 |
November 08, 2024 | 173.04 |
November 07, 2024 | 173.92 |
November 06, 2024 | 174.40 |
November 05, 2024 | 176.93 |
November 04, 2024 | 173.52 |
November 01, 2024 | 173.79 |
October 31, 2024 | 174.00 |
October 30, 2024 | 181.18 |
October 29, 2024 | 183.47 |
October 28, 2024 | 185.01 |
October 25, 2024 | 181.69 |
October 24, 2024 | 183.86 |
October 23, 2024 | 182.98 |
October 22, 2024 | 185.90 |
October 21, 2024 | 184.65 |
October 18, 2024 | 190.16 |
October 17, 2024 | 189.55 |
October 16, 2024 | 189.00 |
October 15, 2024 | 191.55 |
October 14, 2024 | 191.56 |
October 11, 2024 | 188.38 |
October 10, 2024 | 188.59 |
Date | Value |
---|---|
October 09, 2024 | 185.76 |
October 08, 2024 | 182.30 |
October 07, 2024 | 183.34 |
October 04, 2024 | 185.68 |
October 03, 2024 | 184.78 |
October 02, 2024 | 188.74 |
October 01, 2024 | 190.80 |
September 30, 2024 | 193.84 |
September 27, 2024 | 194.67 |
September 26, 2024 | 193.60 |
September 25, 2024 | 189.07 |
September 24, 2024 | 194.12 |
September 23, 2024 | 195.81 |
September 20, 2024 | 199.36 |
September 19, 2024 | 201.44 |
September 18, 2024 | 197.59 |
September 17, 2024 | 198.21 |
September 16, 2024 | 199.58 |
September 13, 2024 | 195.63 |
September 12, 2024 | 197.89 |
September 11, 2024 | 199.09 |
September 10, 2024 | 200.64 |
September 09, 2024 | 199.27 |
September 06, 2024 | 200.81 |
September 05, 2024 | 201.80 |
Total Return Level Definition
The total return level allows investors to view the performance of a security inclusive of both price appreciation and dividends/distributions. Total return level is seen as the most accurate calculation that produces returns consistent with most other sources.
Total Return Level Range, Past 5 Years
165.79
Minimum
Nov 13 2024
414.71
Maximum
Jun 10 2021
260.16
Average
266.39
Median
Total Return Level Benchmarks
Eli Lilly and Co | 2343.87 |
Sage Therapeutics Inc | 5.74 |
Ionis Pharmaceuticals Inc | 37.80 |
Pfizer Inc | 95.41 |
Repligen Corp | 150.43 |